New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
September 13, 2018 - Zydus Pharmaceuticals launched Navinta’s AP-rated generic version of BiCNU (carmustine) 100 mg injection.
Download PDF
Return to publications
